An enzyme that converts p-hydroxycinnamate into p-hydroxybenzoate was found in rat liver. It is localized in the mitochondria and requires ATP. The activity is lost when the mitochondria are stored frozen overnight. Addition of magnesium chloride, cytochrome c, GSH, coenzyme A or potassium cyanide did not have any effect on the activity. When the rats were fed with oc-p-chlorophenoxyisobutyrate, the rate of formation of p-hydroxybenzoate increased twofold. The reaction has some similar properties to fatty acid oxidation, but appears to be different in many respects.
It was shown that [U-14C]tyrosine and [U_14C]-phenylalanine were incorporated into ubiquinone, although to a small extent, in the rat (Olson, Dialameh & Bentley, 1960) and the labelling was localized in the benzoquinone nucleus of ubiquinone (Bentley, Ramsey, Springer, Dialameh & Olson, 1961) . Rudney & Parson (1963) and Olson et al. (1963) have further shown that p-hydroxybenzaldehyde andp-hydroxybenzoate were incorporated more efficiently than tyrosine into ubiquinone. In a system incorporating [U-14C]phenylalanine into ubiquinone with rat liver slices, addition of phydroxybenzoate as well as p-hydroxyphenylpyruvate, p-hydroxyphenyl-lactate, p-hydroxycinnamate, p-hydroxyphenylpropionate, p-hydroxybenzaldehyde,'p-hydroxybenzyl alcohol and benzoate, in vitro, was found to produce a 'dilution effect,' suggesting that these compounds or others derived therefrom are intermediates in the tyrosinep-hydroxybenzoate pathway (Olson, 1965) . Scheme 1 shows the sequence of reactions from tyrosine to p-hydroxybenzoate proposed by Booth, et al. (1960) , based on the excretion pattern of phenolic acids in the urine of rats dosed with tyrosine and other metabolites. In Scheme 1 the conversion of tyrosine into p-hydroxyphenylpyruvate by the transaminase and the following reaction to p-hydroxyphenyl-lactate by an enzyme similar to lactate dehydrogenase (Weber & Zannoni, 1966) are the two steps known so far to be catalysed by enzymes. The work presented in the present paper provides the first evidence for the enzymic conversion of p-hydroxycinnamate into p-hydroxybenzoate in rat liver mitochondria.
MATERIALS AND METHODS
p-Hydroxycinnamate was obtained from Koch-Light Laboratories Ltd., Colnbrook, Bucks., U.K. p-Hydroxybenzoate, ATP, cytochrome c and octanoate were obtained from Sigma Chemical Co., St Louis, Mo., U.S.A. p-Hydroxyphenylpropionate was prepared by hydrogenation of p-hydroxycinnamate with Pd on charcoal as catalyst (Booth et al. 1960) . All other chemicals were of AnalaR grade.
Animal. and preparation of ti88ue8. Albino rats, weighing about 200g, from the stock colony were used. The animals were killed by stunning and decapitation, the livers quickly removed and kept in ice. For the experiments with minces, the livers were sliced with a pair of scissors until a fine mince was obtained. The livers were homogenized in a Potter-Elvehjem-type glass homogenizer in 0.25M-sucrose (10ml/g of liver). Mitochondria were obtained by the conventional differential-centrifugation procedure of Schneider & Hogeboom (1950) and were washed once with the homogenization medium and suspended in 0.25M-sucrose. Incubation conditions and enzyme assay. The reaction mixture consisted of 25 ,mol of potassium phosphate buffer (pH7.4), or 50,tmol of tris-HCl buffer (pH7.4), where mentioned, 5jumol of ATP and 0.2 ml of mitochondrial suspension (about 5-8 mg of protein) in a total volume of 0.5 ml. Incubation was carried out for 60 min, or a specified time, at 370C in a water bath, with reciprocal shaking of the tubes. At the end of the incubation 0.2 ml of lOM-HCl04 was added, the mixture centrifuged and the clear supernatant was extracted three times with 2 ml portions of diethyl ether. The pooled ether extract was evaporated to dryness and the residue was dissolved in a small volume of ethyl acetate for paper chromatography. p-Hydroxybenzoate was separated and determined as described below. The enzyme activity is expressed as nmol of p-hydroxybenzoate formed/h per mg of mitochondrial protein or per g of liver.
All the assays were run in duplicates for each sample. Duplicates showed good agreement and the mean values are given. No p-hydroxybenzoate was formed when p-hydroxycinnamate was incubated with boiled or HC104-treated enzyme.
Separation and determination of p-hydroxybenzoate. The ether extracts were chromatographed on Whatman no. 1 filter paper, with benzene-acetic acid-water (10:7:3, by vol.; organic phase) in one direction and aq. 2% (v/v) formic acid in the other. The phenolic compounds were detected under u.v. light (Mineral light UVS-12). They were further identified by spraying the paper with diazotized p-nitroaniline followed by aq. 5% (w/v) Na2CO3.
Two blue spots corresponding to ci8-and trans-forms of p-hydroxycinnamate (isomerized during chromatography in the first solvent) and a red spot corresponding to p-hydroxybenzoate were obtained on the chromatograms (Fig. 1) . (w/v) NaNO2 solution] and after 2min 0.8ml of aq. 5% (w/v) Na2CO3 solution were added. The volume was made up to 5 ml with water and the colour intensity was read in a Klett-Summerson photoelectric colorimeter with green filter (500-570nm). The readings were proportional to the concentration of p-hydroxybenzoate in the range of 1-150nmol.
The recovery of added p-hydroxybenzoate after incubation, extraction and chromatography was about 95% over the range specified above. It was also found that the colour obtained was stable and the method could be used even after the paper had been sprayed with the reagents for visual detection. 
RESULTS
Experiments with minces. In the first set of experiments liver minces were incubated in 0.05M-potassium phosphate buffer (pH 7.4) with tyrosine, p-hydroxyphenyl-lactate andp-hydroxycinnamate. p-Hydroxybenzoate was formed only when phydroxycinnamate was used. It was found that shaking the reaction mixture in a Dubnoffmetabolic shaker increased considerably the amount of p-hydroxybenzoate formed. No phenolic compound could be detected in the ether extract when tyrosine was used as substrate. Under similar experimental conditions kidney, brain and heart did not show formation of p-hydroxybenzoate from p-hydroxycinnamate. However, when 0.25M-sucrose was used as the medium for incubation, kidney and heart also showed formation of p-hydroxybenzoate.
Experiments with liver homogenates. In the second set of experiments, homogenates of liver were tested for their ability to convert p-hydroxycinnamate to p-hydroxybenzoate. The activity could be detected only with homogenates made in 0.25M-sucrose andnot in 1.1% (w/v) potassiumLchloride or 0.05M-potassium phosphate buffer (pH7.4). Addition of nicotinamide, GSH, ferrous sulphate or sodium-hydrogensulphite did not show any effect. The activity could be enhanced by adding ATP (Table 1 ). The lack of activity in some cases was not due to destruction of p-hydroxybenzoate, because added p-hydroxybenzoate under the incubation conditions with homogenates was quantitatively recovered. The activity was found in the pH range 5.5-8.0 and was maximal around neutral pH values. When the homogenates in sucrose were stored frozen overnight, the activity was completely lost.
Experiments with mitochondria. On fractionation of the homogenates in sucrose into cell components and testing them, the activity was localized in the mitochondrial fraction (Table 2) . Therefore further experiments were carried out with mitochondria.
Mitochondrial suspension (about 120mg of protein) was incubated with 10,umol of p-hydroxycinnamate, 100 ,.mol of ATP and 1 mmol of tris-HCl buffer, pH 7.4, for 2 h in a Dubnoff metabolic shaker (-) and alkaline (----), solutions in ethanol. (Fig. 3) . The activity increased with increase in substrate concentration and the Km for p-hydroxycinnamate calculated from the Lineweaver-Burk plot was 3.1 x 10-4M (Fig. 4) Effect of feeding with oc-p-Chlorophenoxyisobutyrate ethyl ester. It was found in this laboratory that feeding rats with this drug, which is antihypercholesterolemic (Thorp & Waring, 1962) , increased the hepatic concentration of ubiquinone (Krishnaiah, Inamdar & Ramasarma, 1967) and its synthesis from [2-'4C]mevalonate (Krishnaiah & Ramasarma, 1969) . It was therefore decided to see whether the formation of p-hydroxybenzoate increases after feeding with this drug. The results in Table 5 show that formation of p-hydroxybenzoate increased twofold without affecting fatty acid oxidation in mitochondria, obtained from livers of rats fed for 15 days with 0.5% (w/w) of the drug in the diet. This increase was also observed with c-p-chlorophenoxyisobutyric acid (sodium salt) feeding, along with the lowering of serum sterol (Kritchevsky, Tepper, Sallata, Kabakjeen & Cristofalo, 1969) and elevation of hepatic ubiquinone (T. P. Krishnakanta & C. K. Ramakrisina Kurup, unpublished results).
DISCUSSION
The postulated conversion of p-hydroxycinnamate into p-hydroxybenzoate (Booth et al. 1960 ) is supported by the demonstration of such an enzymic conversion in the mitochondria. Although it is apparent from some of the properties that this is probably similar to the f-oxidation type of reactions there are some distinctive features. Knoop (1904) has shown that phenyl-substituted fatty acids undergo P-oxidation in intact animals. It is therefore appropriate to compare our system with fatty acid oxidation systems.
The requirement for fresh mitochondria and ATP in the media used is shared by the two systems. p-Hydroxybenzoate formation was irreversibly lost in aged mitochondria, whereas octanoate oxidation could be partially restored by the addition of fumarate. It does not resemble the GTP-dependent system for activation of fatty acids (Galzigna, Rossi, Sartorelli & Gibson, 1967) 
between the two systems is the increase in the rate of conversion of p-hydroxycinnamate into phydroxybenzoate without altering the rate of octanoate oxidation in a-p-chlorophenoxyisobutyrate-treated animals. It would be of value to know the fate of the C2 fragment, the second product of the reaction. If the reaction were similar to the #-oxidation type of reactions, the two carbon atoms will be converted into C02 via acetyl-CoA. An alternative possibility exists, that the second product may be oxalate, since it was reported that oxalate was formed from the side chain of tyrosine and excreted in the urine in the rat (Cook & Henderson, 1969) . This requires further investigation.
Many other questions also arise. There may be some intermediates between p-hydroxycinnamate andp-hydroxybenzoate. The part ofthep-hydroxycinnamate not accounted for in stoicheiometry studies may be in the form of bound intermediates. The product p-hydroxybenzoate could be in the form of a CoA derivative in equilibrium with the free substance, or it may be a direct product. The requirement for the large amount of ATP remains to be explained. Addition of oligomycin did not give any change in-the rate of formation of phydroxybenzoate, implying the absence of involve. ment of high-energy intermediates. The possibility of the activation of the carboxyl group, the energy being provided by ATP, is still not ruled out. ATP may also be serving to protect the inlitochondria from swelling.
The specific increase in the rate of formation of p-hydroxybenzoate in the chlorophenoxyisobutyrate-treated animals deserves special mention. Ubiquinone content increases during this treatment, and it is logical that the formation of p-hydroxybenzoate, the precursor ofthe ring ofubiquinone, also increased which may be responsible for the observed increase in ubiquinone. This adds indirect support for the idea that this system is responsible for the physiological formation of p-hydroxybenzoate.
